These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17396098

  • 1. [Can metabolic steatohepatitis be treated?].
    Ratziu V, Vispo M, Tahiri M, Bonyhay L, de Torres M, Bernhardt C, Poynard T, Lebray P.
    Gastroenterol Clin Biol; 2007 Mar; 31(3):333-40. PubMed ID: 17396098
    [No Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease.
    Paredes AH, Torres DM, Harrison SA.
    Clin Liver Dis; 2012 May; 16(2):397-419. PubMed ID: 22541706
    [Abstract] [Full Text] [Related]

  • 3. Nonalcoholic fatty liver disease: pharmacologic and surgical options.
    Parikh N, Ahmad J.
    Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273
    [Abstract] [Full Text] [Related]

  • 4. Current and emerging therapies in nonalcoholic fatty liver disease.
    Kashi MR, Torres DM, Harrison SA.
    Semin Liver Dis; 2008 Nov; 28(4):396-406. PubMed ID: 18956296
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic therapy of non-alcoholic steatohepatitis.
    Ratziu V, Zelber-Sagi S.
    Clin Liver Dis; 2009 Nov; 13(4):667-88. PubMed ID: 19818312
    [Abstract] [Full Text] [Related]

  • 6. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
    Federico A, Zulli C, de Sio I, Del Prete A, Dallio M, Masarone M, Loguercio C.
    World J Gastroenterol; 2014 Dec 07; 20(45):16841-57. PubMed ID: 25492998
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expert opinion on current therapies for nonalcoholic fatty liver disease.
    Della Corte C, Alisi A, Iorio R, Alterio A, Nobili V.
    Expert Opin Pharmacother; 2011 Aug 07; 12(12):1901-11. PubMed ID: 21639814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pioglitazone in nonalcoholic steatohepatitis.
    Chavez-Tapia NC, Barrientos-Gutierrez T, Uribe M.
    N Engl J Med; 2007 Mar 08; 356(10):1067-8; author reply 1068-9. PubMed ID: 17354302
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Postgrad Med J; 2006 May 08; 82(967):315-22. PubMed ID: 16679470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Non-alcoholic steatohepatitis].
    Rakov AL, Gorbakov VV, Vecherinina OO.
    Voen Med Zh; 2006 Jul 08; 327(7):33-9. PubMed ID: 16977879
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A, Merriman RB, Bass NM.
    Clin Liver Dis; 2007 Feb 08; 11(1):119-40, ix. PubMed ID: 17544975
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of nonalcoholic steatohepatitis: an evidence-based approach.
    Mahady SE, George J.
    Clin Liver Dis; 2012 Aug 08; 16(3):631-45. PubMed ID: 22824485
    [Abstract] [Full Text] [Related]

  • 20. [Therapeuric aspects of NAFLD. A literature review].
    Tapia NC, Avila FI, Leiva JG, Ramos MH, Avila JF, Uribe M.
    Rev Gastroenterol Mex; 2006 Aug 08; 71(4):487-95. PubMed ID: 17542283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.